Donate
Post 4 Prevention
Home 2017-09-29T17:50:03+00:00

HeritX is the only organization focused solely on preventing inherited cancer.

Join the Mailing List

“Typically, when people think about cancer research they think about finding cures, but the goal of this nonprofit is prevention, specifically for people with the BRCA gene … The potential here is transformative.”

– Linsey Davis, Good Morning America

Fact: 1 in 3 people will be diagnosed with cancer in their lifetime, and the numbers are rising. Only prevention can stop this.

HeritX is changing the approach to cancer by putting prevention first. Prevention is the only way to spare our loved ones the trauma of cancer and its treatment.

Fact: People born with a BRCA gene mutation face an up to 90% risk of developing not only one but multiple kinds of cancer.

Millions of families are threatened by inherited BRCA cancer, generation after generation. They urgently need a preventive therapy.

Fact: Despite decades of research, cancer treatment is still agonizing and it takes an average of 15 years to develop new medicines.

HeritX has designed an accelerated roadmap to achieve a safe prevention in less than 10 years.

Inherited BRCA cancer prevention will be the gateway to all cancer prevention.

You can enable transformative progress and make cancer prevention a reality.

Donate
Join the Movement
Post 4 Prevention

We collaborate with top scientists from more than 10 recognized institutions in five countries, including:

HeritX News

HeritX Announces the Appointment of Points Group CEO Thomas Hofstetter to the HeritX BoardHeritX Announces the Appointment of Points Group CEO Thomas Hofstetter to the HeritX Board

February 20th, 2018|Comments Off on HeritX Announces the Appointment of Points Group CEO Thomas Hofstetter to the HeritX BoardHeritX Announces the Appointment of Points Group CEO Thomas Hofstetter to the HeritX Board

HeritX Announces the Appointment of Points Group CEO Thomas Hofstetter to the HeritX Board FLORHAM PARK, NJ (February 20, 2018) – HeritX announces the appointment of Thomas Hofstetter, Chief Executive Officer (CEO) and Founder of [...]

HeritX: Putting Prevention First This National Cancer Prevention Month

February 16th, 2018|Comments Off on HeritX: Putting Prevention First This National Cancer Prevention Month

HeritX: Putting Prevention First This National Cancer Prevention Month February is National Cancer Prevention Month. It is intended to put cancer squarely in the public eye. The hope is that one day, there will be [...]

HeritX researcher discovers new function for BRCA1

December 24th, 2017|Comments Off on HeritX researcher discovers new function for BRCA1

HeritX researcher discovers new function for BRCA1 One of the earliest cancer prevention projects HeritX funded is in the lab of Dr. Ralph Scully at Beth Israel Deaconess Medical Center. We are excited to share [...]

HeritX Sponsor Recently Featured in Reader’s Digest

November 15th, 2017|Comments Off on HeritX Sponsor Recently Featured in Reader’s Digest

HeritX Sponsor Recently Featured in Reader's Digest Our very own sponsor and supporter Wendy Felson was featured in a recent Reader's Digest article regarding her BRCA diagnosis. Wendy--together with 13 other women--discussed the impact the [...]

Read All News